Mode
Text Size
Log in / Sign up

Extended lymphadenectomy during radical cystectomy for bladder cancer may improve disease-free survivalExtended lymphadenectomy may improve survival for some bladder cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that extended lymphadenectomy may improve disease-free survival but carries a risk of longer operative times.

The study evaluated the clinical impact of extended lymphadenectomy compared to non-extended lymphadenectomy in adults undergoing radical cystectomy for bladder cancer. The analysis included a variety of study designs to assess outcomes such as surgery duration, disease-free survival, and recurrence-free survival.

Findings indicated that extended lymphadenectomy was associated with longer operative times. Regarding survival outcomes, the data suggested an improvement in disease-free survival for the extended group, while recurrence-free survival appeared higher in the non-extended group. However, the authors noted that the evidence base was primarily composed of observational studies, with only a small portion of the included studies being randomized controlled trials.

Several limitations were noted, including moderate to high heterogeneity and very low certainty of evidence for most outcomes. The authors also noted low certainty of evidence for overall survival when considering only randomized controlled trials. Due to these factors and the lack of consistent oncologic benefit across all metrics, the clinical relevance of extended lymphadenectomy remains inconclusive. Practitioners should weigh the increased operative time against the potentially inconsistent survival benefits when making surgical decisions.

When a person is diagnosed with bladder cancer, the surgical plan is one of the most important decisions for their long-term health. One key part of that surgery is removing lymph nodes, which are the tiny structures that help the body fight infection and can sometimes carry cancer cells. Doctors have debated whether a more extensive removal of these nodes, called extended lymphadenectomy, provides a significant benefit for patients undergoing a radical cystectomy (the removal of the bladder). This research looks at whether that extra effort in the operating room actually changes how well patients do over time.

To find the answer, researchers looked at data from 5,671 adults who underwent surgery for bladder cancer. They compared patients who had the standard procedure against those who underwent the extended lymphadenectomy. The goal was to see if the extra time and effort in the operating room led to better outcomes, such as keeping the cancer from coming back or helping the patient live longer.

The results showed a few different things. The extended procedure did take more time, adding about 26 minutes to the surgery. However, the data showed an improvement in disease-free survival, which is the amount of time a patient lives without the cancer returning. On the other hand, the data for recurrence-free survival actually showed a higher rate in the group that did not have the extended procedure. These mixed results make it hard to say for certain if the extra surgery is always better.

It is important to look at these findings with a cautious eye. The researchers noted that the evidence is not very strong. Most of the studies used to reach these conclusions were not randomized controlled trials, which are the gold standard for medical research. Because of this, the certainty of the evidence is considered very low for most outcomes. This means that while the data shows a possible benefit in some areas, it is not a clear win for one method over the other.

For patients today, this means that the choice of surgery is still a complex conversation to have with a surgical team. While the extended procedure might offer some benefits, it is not a guaranteed way to improve survival for everyone. Because the evidence is still limited and inconsistent, doctors will continue to weigh the risks and benefits of each approach based on the specific needs of the individual patient.

What this means for you:
Extended lymph node removal may improve some survival rates, but the evidence is currently inconsistent and weak.

Study Details

Study typeMeta analysis
Sample sizen = 5,671
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Pelvic lymph node dissection is an essential component of radical cystectomy (RC) for bladder cancer (BC), but the optimal extent of lymphadenectomy remains uncertain. We conducted a systematic review and meta-analysis to compare oncologic and perioperative outcomes between extended and non-extended lymphadenectomy during RC for BC. PubMed/MEDLINE, Embase, and ClinicalTrials. gov were searched up to October 2025 following PRISMA guidelines and PROSPERO registration. Randomized controlled trials (RCTs) and observational studies comparing extended versus non-extended lymphadenectomy in adults undergoing RC were included. Outcomes included surgery duration, intraoperative blood loss, overall survival (OS), disease-free survival (DFS), recurrence-free survival (RFS), and cancer-specific survival (CSS). Random-effects meta-analyses were performed, reporting hazard ratios (HRs) or mean differences (MDs) with 95% confidence intervals (CIs). Risk of bias was assessed using RoB 2.0 and ROBINS-I, and certainty of evidence using GRADE. Fifteen studies including 5671 patients were analyzed, of which two were RCTs. Extended lymphadenectomy was associated with longer operative time (MD + 26.2 min) and improved DFS (HR: 1.47), but no significant benefit in OS or CSS. Non-extended lymphadenectomy was associated with higher RFS (HR: 0.79). Heterogeneity was moderate to high, and certainty of evidence was very low for most outcomes and low for OS considering only RCTs. Extended lymphadenectomy during RC increases operative time and may improve DFS; however, the available evidence does not clearly support a consistent oncologic benefit.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.